ABVC BioPharma, Inc. (ABVC) Operating income 2016–2025
ABVC BioPharma, Inc. (ABVC) annual operating income history from SEC filings — each fiscal year as reported.
-$7.2MFY2025 · since FY2016: -$11.0M → -$7.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.2M | -52.0% |
| FY2024 | -$4.7M | +30.5% |
| FY2023 | -$6.8M | +55.2% |
| FY2022 | -$15.1M | -29.1% |
| FY2021 | -$11.7M | -37.6% |
| FY2020 | -$8.5M | -145.9% |
| FY2019 | -$3.5M | -24.2% |
| FY2018 | -$2.8M | +32.7% |
| FY2017 | -$4.1M | +62.4% |
| FY2016 | -$11.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice